Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

584 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Prostate cancer castrate resistant progression usage of non-canonical androgen receptor signaling and ketone body fuel.
Labanca E, Bizzotto J, Sanchis P, Anselmino N, Yang J, Shepherd PDA, Paez A, Antico-Arciuch V, Lage-Vickers S, Hoang AG, Tang X, Raso MG, Titus M, Efstathiou E, Cotignola J, Araujo J, Logothetis C, Vazquez E, Navone N, Gueron G. Labanca E, et al. Among authors: logothetis c. Oncogene. 2021 Nov;40(44):6284-6298. doi: 10.1038/s41388-021-02008-9. Epub 2021 Sep 28. Oncogene. 2021. PMID: 34584218 Free PMC article.
Targeting prostate cancer bone metastases.
Logothetis C, Tu SM, Navone N. Logothetis C, et al. Cancer. 2003 Feb 1;97(3 Suppl):785-8. doi: 10.1002/cncr.11130. Cancer. 2003. PMID: 12548576 Free article. No abstract available.
Targeting Src signaling in metastatic bone disease.
Araujo J, Logothetis C. Araujo J, et al. Among authors: logothetis c. Int J Cancer. 2009 Jan 1;124(1):1-6. doi: 10.1002/ijc.23998. Int J Cancer. 2009. PMID: 18942061 Review.
A Phase II Study of Cabozantinib and Androgen Ablation in Patients with Hormone-Naïve Metastatic Prostate Cancer.
Corn PG, Zhang M, Nogueras-Gonzalez GM, Xiao L, Zurita AJ, Subudhi SK, Tu SM, Aparicio AM, Coarfa C, Rajapakshe K, Huang S, Navone NM, Lin SH, Wang G, Ramachandran S, Titus MA, Panaretakis T, Gallick GE, Efstathiou E, Troncoso P, Logothetis C. Corn PG, et al. Among authors: logothetis c. Clin Cancer Res. 2020 Mar 1;26(5):990-999. doi: 10.1158/1078-0432.CCR-19-2389. Epub 2020 Jan 15. Clin Cancer Res. 2020. PMID: 31941830 Clinical Trial.
584 results